Perioperative atrial fibrillation: Difference between revisions

From IDWiki
(Created page with "== Background == * Refers to atrial fibrillation that occurs during or immediately following non-cardiac surgery ** Excludes patients with known persistent or paroxysmal...")
 
No edit summary
 
Line 1: Line 1:
== Background ==
==Background==


* Refers to [[atrial fibrillation]] that occurs during or immediately following non-cardiac surgery
*Refers to [[atrial fibrillation]] that occurs during or immediately following non-cardiac surgery
** Excludes patients with known persistent or paroxysmal [[atrial fibrillation]]
**Excludes patients with known persistent or paroxysmal [[atrial fibrillation]]
*Occurs in 30% after thoracic surgery and in 1-20% of non-thoracic, non-cardiac surgery


== Clinical Manifestations ==
==Clinical Manifestations==


* Irregularly irregular heart rhythm with atrial fibrillation on ECG
*Irregularly irregular heart rhythm with atrial fibrillation on ECG, usually within the first 4 days postoperatively
* High rates of spontaneous cardioversion
*High rates of spontaneous cardioversion


== Management ==
==Management==


* Screen patients with known atrial fibrillation with telemetry for 24 to 48 hours after surgery
*Screen patients with known atrial fibrillation with telemetry for 24 to 48 hours after surgery
* If hemodynamically unstable, consider electric cardioversion as per typical [[atrial fibrillation]]
*If hemodynamically unstable, consider electric cardioversion as per typical [[atrial fibrillation]]
* Rate control with β blockers to target HR <100 bpm (alternatives include [[calcium channel blockers]] or [[digoxin]])
*Rate control with β blockers to target HR <100 bpm (alternatives include [[calcium channel blockers]] or [[digoxin]])
* Unclear whether long-term anticoagulation is indicated; the ASPIRE-AF will hopefully answer this question
*Unclear whether long-term anticoagulation is indicated; the ASPIRE-AF will hopefully answer this question
** Consider evaluating with CHA<sub>2</sub>DS<sub>2</sub>-VASc, though not validated in the patient population
**Consider evaluating with CHA<sub>2</sub>DS<sub>2</sub>-VASc, though not validated in the patient population
** Timing of anticoagulation would need to be discussed with the surgeon
**Timing of anticoagulation would need to be discussed with the surgeon
* Arrange outpatient echocardiogram and extended Holter monitor (14 days)
*Arrange outpatient echocardiogram and extended Holter monitor (14 days)


[[Category:Perioperative medicine]]
[[Category:Perioperative medicine]]

Latest revision as of 16:21, 7 May 2021

Background

  • Refers to atrial fibrillation that occurs during or immediately following non-cardiac surgery
  • Occurs in 30% after thoracic surgery and in 1-20% of non-thoracic, non-cardiac surgery

Clinical Manifestations

  • Irregularly irregular heart rhythm with atrial fibrillation on ECG, usually within the first 4 days postoperatively
  • High rates of spontaneous cardioversion

Management

  • Screen patients with known atrial fibrillation with telemetry for 24 to 48 hours after surgery
  • If hemodynamically unstable, consider electric cardioversion as per typical atrial fibrillation
  • Rate control with β blockers to target HR <100 bpm (alternatives include calcium channel blockers or digoxin)
  • Unclear whether long-term anticoagulation is indicated; the ASPIRE-AF will hopefully answer this question
    • Consider evaluating with CHA2DS2-VASc, though not validated in the patient population
    • Timing of anticoagulation would need to be discussed with the surgeon
  • Arrange outpatient echocardiogram and extended Holter monitor (14 days)